Brentuximab vedotin in T-cell lymphoma

Van der Weyden, C; Dickinson, M; Whisstock, J; Prince, HM

Van der Weyden, C (reprint author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.

EXPERT REVIEW OF HEMATOLOGY, 2019; 12 (1): 5

Abstract

Introduction: Brentuximab vedotin is an antibody-drug conjugate, which combines a CD30 monoclonal antibody with the microtubule-disrupting agent monom......

Full Text Link